Intervention not reported
Adverse events (grade 3 or 4) · HIV‐positive adults
The intervention probably leads to higher adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
- Interleukin‐2 as an adjunct to antiretroviral therapy for HIV‐positive adults 2017 · Cochrane Headline outcomes onlyRR 1.47 [1.1, 1.96]6 studies · 6291 participantsModerate